Tylenol3

  • Uploaded by: Cassie
  • 0
  • 0
  • November 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Tylenol3 as PDF for free.

More details

  • Words: 392
  • Pages: 1
NURS 2516 Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name

Trade Name Acetaminophen Tylenol 3 Codeine

Classification Antipyretics/ nonopiod analgesics /opioid analgesics

Peak

Onset

Duration

A:1-3 hours C:60-120 minutes

0.5-1 hour 30-45 minutes

3-8 hours 4 hours

Dose

Route

Time/frequency

300 mg/ 30mg

PO

Every 6 hrs. PRN for pain

For IV meds, compatibility with IV drips and /or solutions N/A

Mechanism of action and indications (Why med ordered)

Nursing Implications (what to focus on) Contraindications/warnings/interactions

A: Inhibits the synthesis of prostaglandins that may serve as mediators of pain and fever, primarily in the CNS. Indicated for treatment of mild pain. C: Binds to opipate receptors in the CNS. Alters the perceprion of and response to painful stimuli while producing generalized CNS depression.

A: Hypersensitivity. Use cautiously in pt’s w/ malnutrition. Interacts w/ hepatotoxic substances and NSAID’s. Do not give more than 4 g of aceteminophin in 24 hours. C:Contraindicated in hypersensitivity. Use cautiously in head trauma, increased intracranial pressure, Severe renal, hepatic, or pulmonary disease, hypothyroidism, Adrenal insufficiency.

Common side effects A: Hepatotoxicity, renal failure, neutropenia, pancytopenia, leucopenia, rash, and urticaria C:confusion, sedation, hypotension, constipation, nausea, vomiting

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) NSAIDS, increased sedative effect with other CNS depressants.

Lab value alterations caused by medicine May alter results of blood glucose monitoring, Increased serum bilirubin, LDH, AST, ALT, and prothrombin time may indicate hepatotoxicity. May cause and increase in serum amylase and lipase concentrations.

Be sure to teach the patient the following about this medication Advise patient to consult health care professional if discomfort or fever is not relieved by routine doses of this drug or if fever is greater than 39.5°C (103°F) or lasts longer than 3 days. Oral doses may be administered with food or milk to prevent GI irritation.

Nursing Process- Assessment (Pre-administration assessment) Assess for Pain: intensity, location , duration etc. Assess respirations , number, depth, quality, and if <10 assess for level of sedation. Assess bowel function regularly. Institute bowel protocol including increased intake of fluids and fiber to prevent constipation.

Assessment Why would you hold or not give this med? If the patient reports no pain or if respirations are less than 12

Evaluation Check after giving Decrease in Level of pain reported by the patient with minimal side effects.

Related Documents

Tylenol3
November 2019 35

More Documents from "Cassie"

Prednisone
November 2019 36
Tylenol3
November 2019 35
New
November 2019 76
Miralax
November 2019 39
Furosemide
November 2019 35
2.pptx
December 2019 35